|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Current assets | |||||||||
| Cash | |||||||||
| Prepaid expenses | |||||||||
| Total Current Assets | |||||||||
| Deferred offering costs | |||||||||
| Long-term prepaid insurance | |||||||||
| Marketable securities held in Trust Account | |||||||||
| Total Assets | |||||||||
| Current liabilities | |||||||||
| Accounts payable and accrued expenses | |||||||||
| Accrued offering costs | |||||||||
| Due to Sponsor | |||||||||
| Sponsor | |||||||||
| Total due to Sponsor | |||||||||
| Promissory note - related party | |||||||||
| Total Liabilities | |||||||||
| Total Current Liabilities | |||||||||
| Class A ordinary shares subject to possible redemption, 23,000,000 shares at redemption value of $10.83 and $10.55 per share as of September 30, 2026 and December 31, 2025, respectively | |||||||||
| Class A Ordinary Shares | |||||||||
| Total class A ordinary shares subject to possible redemption, 23,000,000 shares at redemption value of $10.83 and $10.55 per share as of September 30, 2026 and December 31, 2025, respectively | |||||||||
| Shareholders’ (Deficit) Equity | |||||||||
| Ordinary shares, value | |||||||||
| Class A Ordinary Shares | |||||||||
| Class B Ordinary Shares | |||||||||
| Additional paid-in capital | |||||||||
| (Accumulated deficit) retained earnings | |||||||||
| Total Shareholders’ (Deficit) Equity | |||||||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ (Deficit) Equity |
Loading...